siRNA therapy reduces triglycerides in individuals along with rare condition
.ANALYSIS FEATURE.19 September 2024.
Plozasiran minimized triglyceride amounts through 80% as well as lowered the danger of pancreatitis in clients with chronic chylomicronemia, along with or without a hereditary medical diagnosis.